These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20520630)

  • 1. Targeting X-linked inhibitor of apoptosis protein to increase the efficacy of endoplasmic reticulum stress-induced apoptosis for melanoma therapy.
    Hiscutt EL; Hill DS; Martin S; Kerr R; Harbottle A; Birch-Machin M; Redfern CP; Fulda S; Armstrong JL; Lovat PE
    J Invest Dermatol; 2010 Sep; 130(9):2250-8. PubMed ID: 20520630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic B-RAF signaling in melanoma impairs the therapeutic advantage of autophagy inhibition.
    Armstrong JL; Corazzari M; Martin S; Pagliarini V; Falasca L; Hill DS; Ellis N; Al Sabah S; Redfern CP; Fimia GM; Piacentini M; Lovat PE
    Clin Cancer Res; 2011 Apr; 17(8):2216-26. PubMed ID: 21270111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting GRP78 to enhance melanoma cell death.
    Martin S; Hill DS; Paton JC; Paton AW; Birch-Machin MA; Lovat PE; Redfern CP
    Pigment Cell Melanoma Res; 2010 Oct; 23(5):675-82. PubMed ID: 20546536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-linked inhibitor of apoptosis protein as a therapeutic target in metastatic melanoma.
    Tian F; Lee SW
    J Invest Dermatol; 2010 Sep; 130(9):2169-72. PubMed ID: 20711206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis.
    Ehrenschwender M; Bittner S; Seibold K; Wajant H
    Cell Death Dis; 2014 Dec; 5(12):e1570. PubMed ID: 25501831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting x-linked inhibitor of apoptosis protein for melanoma therapy: the need for more homogeneous samples and the importance of cell lines.
    Kwatra SG
    J Invest Dermatol; 2011 Mar; 131(3):797. PubMed ID: 21068753
    [No Abstract]   [Full Text] [Related]  

  • 7. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma.
    Ndozangue-Touriguine O; Sebbagh M; Mérino D; Micheau O; Bertoglio J; Bréard J
    Oncogene; 2008 Oct; 27(46):6012-22. PubMed ID: 18560353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications.
    Fernández Y; Verhaegen M; Miller TP; Rush JL; Steiner P; Opipari AW; Lowe SW; Soengas MS
    Cancer Res; 2005 Jul; 65(14):6294-304. PubMed ID: 16024631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining the endoplasmic reticulum stress-inducing agents bortezomib and fenretinide as a novel therapeutic strategy for metastatic melanoma.
    Hill DS; Martin S; Armstrong JL; Flockhart R; Tonison JJ; Simpson DG; Birch-Machin MA; Redfern CP; Lovat PE
    Clin Cancer Res; 2009 Feb; 15(4):1192-8. PubMed ID: 19228725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of endoplasmic reticulum stress-induced cell death by ATF4 in neuroectodermal tumor cells.
    Armstrong JL; Flockhart R; Veal GJ; Lovat PE; Redfern CP
    J Biol Chem; 2010 Feb; 285(9):6091-100. PubMed ID: 20022965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of bortezomib on reverse multidrug resistance and XIAP expression in imatinib-resistant primary cells of chronic myeloid leukemia in blastic crisis].
    Zhao J; Ma LM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):899-904. PubMed ID: 23998582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways.
    Amschler K; Schön MP; Pletz N; Wallbrecht K; Erpenbeck L; Schön M
    J Invest Dermatol; 2010 Apr; 130(4):1073-86. PubMed ID: 19940859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis.
    Hörnle M; Peters N; Thayaparasingham B; Vörsmann H; Kashkar H; Kulms D
    Oncogene; 2011 Feb; 30(5):575-87. PubMed ID: 20856198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib.
    Lecis D; Drago C; Manzoni L; Seneci P; Scolastico C; Mastrangelo E; Bolognesi M; Anichini A; Kashkar H; Walczak H; Delia D
    Br J Cancer; 2010 Jun; 102(12):1707-16. PubMed ID: 20461078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress.
    Lovat PE; Corazzari M; Armstrong JL; Martin S; Pagliarini V; Hill D; Brown AM; Piacentini M; Birch-Machin MA; Redfern CP
    Cancer Res; 2008 Jul; 68(13):5363-9. PubMed ID: 18593938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: the role of stress proteins ERdj5 and ERp57.
    Corazzari M; Lovat PE; Armstrong JL; Fimia GM; Hill DS; Birch-Machin M; Redfern CP; Piacentini M
    Br J Cancer; 2007 Apr; 96(7):1062-71. PubMed ID: 17353921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress.
    Jiang CC; Lucas K; Avery-Kiejda KA; Wade M; deBock CE; Thorne RF; Allen J; Hersey P; Zhang XD
    Cancer Res; 2008 Aug; 68(16):6708-17. PubMed ID: 18701495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of proteasome inhibitor bortezomib on proliferation, apoptosis and XIAP expression in K562 cells].
    Shao M; Sun L; Cui XY; Han XF; Chen SM; Wang F; Zhang H; Ling Z
    Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):182-6. PubMed ID: 21535957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bortezomib blocks the catabolic process of autophagy via a cathepsin-dependent mechanism, affects endoplasmic reticulum stress and induces caspase-dependent cell death in antiestrogen-sensitive and resistant ER+ breast cancer cells.
    Periyasamy-Thandavan S; Jackson WH; Samaddar JS; Erickson B; Barrett JR; Raney L; Gopal E; Ganapathy V; Hill WD; Bhalla KN; Schoenlein PV
    Autophagy; 2010 Jan; 6(1):19-35. PubMed ID: 20110775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA.
    Qin JZ; Xin H; Sitailo LA; Denning MF; Nickoloff BJ
    Cancer Res; 2006 Oct; 66(19):9636-45. PubMed ID: 17018621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.